The dual benefit makes it particularly valuable for the large overlap population of people who are both overweight and insulin resistant
GLP-1 weight loss medications have become a cornerstone of medically supervised weight loss , helping patients reduce appetite, improve portion control, and support sustainable fat loss
By addressing both the physical and psychological aspects of hunger, the medication supports sustainable weight loss and improved metabolic function, helping people regain control over their health
Grazioli, S
However, while GLP-1 RAs did not exhibit an increased risk of acute pancreatitis, DPP-4 inhibitors demonstrated a notable risk elevation (rate ratio, 1.75) [53]
The need of the hour is to help them reach and maintain optimal glycemic (blood sugar) control, keeping such worries at bay